BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32504176)

  • 1. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
    Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
    AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
    Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
    Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study.
    Alsaidan OA; Zafar A; Yasir M; Alzarea SI; Alqinyah M; Khalid M
    Gels; 2022 Oct; 8(11):. PubMed ID: 36354595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of carteolol chitosomes for ocular delivery: formulation optimization,
    Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Alharbi KS; Yasir M; Elmowafy M; Ansari MJ; Salahuddin M; Alshehri S
    Cutan Ocul Toxicol; 2021 Dec; 40(4):338-349. PubMed ID: 34340615
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
    Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
    Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
    Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alotaibi NH; Alshehri S; Alhakamy NA; Alzarea AI; Afzal M; Elmowafy M
    Int J Nanomedicine; 2020; 15():4717-4737. PubMed ID: 32636627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
    Abdelbary G
    Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
    Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
    J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J; Sultana Y; Aqil M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and Evaluation of Moxifloxacin Loaded Bilosomes In-Situ Gel: Optimization to Antibacterial Evaluation.
    Zafar A; Alsaidan OA; Imam SS; Yasir M; Alharbi KS; Khalid M
    Gels; 2022 Jul; 8(7):. PubMed ID: 35877503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models.
    Abdelkader H; Ismail S; Hussein A; Wu Z; Al-Kassas R; Alany RG
    Int J Pharm; 2012 Aug; 432(1-2):1-10. PubMed ID: 22575752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
    Kaskoos RA
    Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
    Öztürk AA; Kıyan HT
    Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): A preclinical investigation.
    Verma A; Sharma G; Jain A; Tiwari A; Saraf S; Panda PK; Katare OP; Jain SK
    Int J Biol Macromol; 2019 Jul; 133():1142-1155. PubMed ID: 31004631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Chitosan-Coated Niosomal Formulation for Improved Management of Bacterial Conjunctivitis: A Highly Permeable and Efficient Ocular Nanocarrier for Azithromycin.
    Eid HM; Naguib IA; Alsantali RI; Alsalahat I; Hegazy AM
    J Pharm Sci; 2021 Aug; 110(8):3027-3036. PubMed ID: 33940026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
    Shahab MS; Rizwanullah M; Alshehri S; Imam SS
    Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timolol-loaded ethosomes for ophthalmic delivery: Reduction of high intraocular pressure in vivo.
    Uner B; Ozdemir S; Nur Pilevne S; Cenk Celebi AR
    Int J Pharm; 2023 Jun; 640():123021. PubMed ID: 37149109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.